Telehealth Pilot for Early Autism Diagnosis in Georgia
This study is testing a new way to diagnose autism spectrum disorder (ASD) in young children (16-36 months old) in Georgia's Babies Can't Wait (BCW) program. It uses a telehealth approach called the Early Diagnostic Response Model Expanded (EDRM-E) to see if assessments can be done effectively online. The goal is to make it easier and faster for children at moderate or high risk for ASD to get a diagnosis. Researchers want to see how many assessments can be completed this way and if families and providers are happy with the process. The study is currently unclear on its recruitment status.
- Study design
- This is an interventional pilot study planning to enroll 100 participants. It will evaluate a telehealth diagnostic protocol for autism.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed monthly until the end of the study, which is approximately one year, and up to 16 weeks post-intervention.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Early Diagnostic Telehealth Pilot for Moderate- and High-Risk Children: Evaluating Assessment Protocols and Efficiency in Georgia's Early Intervention Program
At a glance
Conditions
NCT07623759
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Emory University
Atlanta, Georgiastudy coordinator listed
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Allison J Schwartz, PhD · PRINCIPAL_INVESTIGATOR · Emory University
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Number of moderate and high-risk referral assessments that were completed entirely via a streamlined telehealth protocolMonthly until the end of the study (approximately one year)
Number of moderate and high-risk referral assessments that can be completed entirely via streamlined telehealth protocol
- Number of participants referred to the Early Diagnostic Response Model Expanded (EDRM-E)End of study (up to 16 weeks post-intervention)
Monthly numbers of high-risk referrals to the EDRM-E pilot project and total number of referrals made to the EDRM-E at the end of the study.
- Number of participants consented in the Early Diagnostic Response Model Expanded (EDRM-E) studyMonthly until the end of the study (approximately one year)
Monthly number of families referred who consent to EDRM-E participation
- Response rate in the Early Diagnostic Response Model Expanded (EDRM-E) studyMonthly until the end of the study (approximately one year)
Response rate will be calculated at project end using the formula \[# of families who consented / # of families referred to project\] x 100 = response rate)
- Number of participants that completed the Early Diagnostic Response Model Expanded (EDRM-E) studyEvery 3 months (Quarterly) until end of study (approximately one year)
Quarterly numbers of participants that completed the EDRM-E assessment protocol and total number of participants who completed EDRM-E assessment protocol at study conclusion
- Time from referral to completion of the programUp to 12 weeks post-intervention
Individual calculation of time from BCW referral to final summary report sent to family using the formula: Date of Final Report sent to family - Date of referral from BCW =Time in EDRM-E pilot